1258884-26-2 Usage
General Description
2,6-dichloro-4-methoxy-3-nitropyridine is a chemical compound with the molecular formula C6H3Cl2N2O3. It is a pyridine derivative with two chlorine atoms, a methoxy group, and a nitro group attached to the pyridine ring. 2,6-dichloro-4-methoxy-3-nitropyridine is commonly used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. Its unique structure and functional groups make it a versatile building block for creating new molecular structures with potential biological or agricultural applications. Additionally, 2,6-dichloro-4-methoxy-3-nitropyridine may have other industrial uses, such as in the manufacturing of dyes or other specialty chemicals. Overall, this chemical compound has potential as a key ingredient in the development of various products for multiple industries.
Check Digit Verification of cas no
The CAS Registry Mumber 1258884-26-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,5,8,8,8 and 4 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1258884-26:
(9*1)+(8*2)+(7*5)+(6*8)+(5*8)+(4*8)+(3*4)+(2*2)+(1*6)=202
202 % 10 = 2
So 1258884-26-2 is a valid CAS Registry Number.
1258884-26-2Relevant articles and documents
SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS
-
Paragraph 0604; 0605, (2015/06/10)
The present invention relates to novel substituted bridged urea compounds, corresponding related analogs, pharmaceutical compositions and methods of use thereof. Sirtuin-modulating compounds of the present invention may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders, which include, but are not limited to, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benefit from increased mitochondrial activity. The present invention also related to compositions comprising a sirtuin-modulating compound in combination with another therapeutic agent.
TRIAZOLO [4, 5 - B] PYRIDIN DERIVATIVES
-
Page/Page column 85, (2011/09/19)
There is provided compounds of formula (I), wherein R1, R2, R3 and R4 have meanings given in the description, and pharmaceutically-acceptable esters, amides, solvates or salts thereof, which compounds are useful
